Cluster headache is one of the most severe type of headache, as it occurs in cyclical patterns or cluster periods. Cluster episodes, which last from weeks to months, are frequently followed by remission periods, during which the headache stops. For months, if not years, there are no headaches during remission. Cluster headache is most frequently experienced between the ages of puberty and middle age, but it can strike anyone at any time. Cluster headache is divided into two categories: episodic and chronic. Episodic cluster headache occurs on a regular basis for one week to a year, followed by a month or more of headache-free time. Chronic cluster headache regularly occurs for more than a year, followed by a headache-free period lasting less than a month.
A person with episodic cluster headache may develop chronic cluster headache and vice versa. One-sided soreness, restlessness, excessive tears, redness of the eye on the afflicted side, runny nose on the affected side, and others are some of the symptoms. The dilatation, or widening, of the blood arteries that feed blood to the brain and face causes cluster headache. The trigeminal nerve, which sends sensations from the face to the brain, is compressed by this dilatation.
Market Dynamics
Increasing prevalence of cluster headache is anticipated to drive the growth of global cluster headache market over the forecast period. For instance, according to the article published in the National Center for Biotechnology Information in April 2018, cluster headache is a primary headache that affects up to 0.1% of the population globally. Patients suffer cluster headache attacks up to eight times a day lasting 15 to 180 minutes. The male to female ratio is approximately 2.5: 1.
Key features of the study:
- This report provides in-depth analysis of the global cluster headache market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cluster headache market based on the following parameters – company highlights, types portfolio, key highlights, financial performance, and market strategies
- Key companies covered as a part of this study include Zosano Pharma, Eli Lilly and Company, Lundbeck Seattle BioPharmaceutical, Winston Laboratories, GlaxoSmithKline plc., ElectroCore Medical LLC, Autonomic Technologies, Inc., AstraZeneca plc., Allergan plc., Bayer AG, F. Hoffmann-La Roche Ltd, Novartis AG, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Sanofi, and AbbVie Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global cluster headache market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cluster headache market
Detailed Segmentation:
- Global Cluster Headache Market, By Type:
- Global Cluster Headache Market, By Drug Type:
- Fast-acting Drugs
- Long-term Drugs
- Short-term Drugs
- Global Cluster Headache Market, By Route of Administration:
- Oral
- Topical
- Intravenous
- Others
- Global Cluster Headache Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Cluster Headache Market, By Region:
- North America
- By Type
- By Drug Type
- Fast-acting Drugs
- Long-term Drugs
- Short-term Drugs
- By Route of Administration
- Oral
- Topical
- Intravenous
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country
- Latin America
- By Type
- By Drug Type
- Fast-acting Drugs
- Long-term Drugs
- Short-term Drugs
- By Route of Administration
- Oral
- Topical
- Intravenous
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Type
- By Drug Type
- Fast-acting Drugs
- Long-term Drugs
- Short-term Drugs
- By Route of Administration
- Oral
- Topical
- Intravenous
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Type
- By Drug Type
- Fast-acting Drugs
- Long-term Drugs
- Short-term Drugs
- By Route of Administration
- Oral
- Topical
- Intravenous
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Drug Type
- Fast-acting Drugs
- Long-term Drugs
- Short-term Drugs
- By Route of Administration
- Oral
- Topical
- Intravenous
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Type
- By Drug Type
- Fast-acting Drugs
- Long-term Drugs
- Short-term Drugs
- By Route of Administration
- Oral
- Topical
- Intravenous
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region/Country
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Zosano Pharma
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Eli Lilly and Company
- Lundbeck Seattle BioPharmaceutical
- Winston Laboratories
- GlaxoSmithKline plc.
- ElectroCore Medical LLC
- Autonomic Technologies, Inc.
- AstraZeneca plc.
- Allergan PLC
- Bayer AG
- Hoffmann-La Roche Ltd
- Novartis AG
- Sun Pharmaceutical Industries Ltd
- Teva Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Company Limited
- Sanofi
- AbbVie Inc.
“*” marked represents similar segmentation in other categories in the respective section.
